Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine
Heart failure (HF) is a global health burden characterized by high morbidity and mortality, necessitating advancements in diagnostic and therapeutic approaches. Molecular diagnostics, encompassing genomics, transcriptomics, proteomics, metabolomics, and epigenetics, offer unprecedented insights into...
Saved in:
| Main Authors: | Ovidiu Țica, Otilia Țica |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/14/1807 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure.
by: О. О. Khanyukov, et al.
Published: (2018-05-01) -
MOLECULAR BIOMARKERS FOR DIAGNOSTICS, RISK STRATIFICATION AND PREDICTION OF CHRONIC HEART FAILURE
by: E. A. Medvedeva, et al.
Published: (2016-08-01) -
Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumors
by: Anthony Pirrello, et al.
Published: (2024-12-01) -
The future of diagnostics: cutting-edge advances in healthcare technology
by: Ashok Kumar Sah, et al.
Published: (2025-06-01) -
Global research landscape of retinoblastoma biomarkers: a multidisciplinary bibliometric analysis based on multiple databases (2005–2025)
by: Zhixin Peng, et al.
Published: (2025-08-01)